Hiv research news. The couple's focus on HIV followed...
Hiv research news. The couple's focus on HIV followed their move to the United States in 1987 to work on their master's degrees at Columbia University. Despite decades of global research and Ghana now planning to introduce an HIV preventive vaccine by 2026, there is still no widely approved HIV vaccine and here rsquo;s why that rsquo;s the case scientifically and practically. 3 days ago · An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. Florida universities, including FSU, FIU Research helps provide a better understanding of diseases, develop new treatments, and improve patient outcomes. These insights have enhanced vaccine and therapeutic development by revealing how broadly neutralizing antibodies work and guiding the design of new immune-targeting strategies. Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. At the National Institutes of Health, the HIV/AIDS research effort is led by the National Institute of Allergy and Infectious Diseases (NIAID). The Trump administration is terminating $600 million in CDC grants for programs supporting HIV and STD prevention and HIV surveillance. says the federal government is calling off around $500 million worth of vaccine development projects that use mRNA technology. Gut microbes bolster immunity in HIV patients, research reveals by Weizmann Institute of Science edited by Lisa Lock, reviewed by Robert Egan Editors' notes Discover the treatments and prevention methods that are bringing us closer to an HIV cure, such as a possible vaccine, PrEP, PEP, and more. HIV incidence HIV incidence refers to the estimated number of new HIV infections in a given year. New Research Highlights Gains and Vulnerabilities in SA's Shift to DTG-Based ART research-publication-news university-of-cape-town dolutegravir hiv-treatment-south-africa treatment-interruptions 40 years after the HIV virus was first identified, researchers have uncovered an unexpected second function of one of the virus’s key proteins, a discovery that could pave the way for new types of treatments. MHRP investigators will deliver early findings from the trial during an oral presentation at the 2026 PrEP is for people without HIV who may be exposed to HIV through sex or injection drug use. Dec 12, 2025 · Research into T cells holds the potential to make advances in HIV therapies and the treatment of conditions such as cancer and autoimmune diseases. ” In this study, co-first authors Alan Tomusiak from the Buck Institute for Research on Aging and the University of Utilizing data from Stichting HIV monitoring (SHM) and Statistics Netherlands, a study published in the journal Nature Communications has compared labor market outcomes of 5,960 people diagnosed A paper in the New England Journal of Medicine published the findings of the LATITUDE study, a phase three efficacy study of the long-acting injectable antiretroviral therapies cabotegravir and rilpivirine in those who have been diagnosed with HIV and have a history of adherence challenges. Consider PrEP as part of a comprehensive HIV prevention plan that includes discussing how to take PrEP as prescribed, proper condom use, screening for other sexually transmitted infections (STIs), and other risk-reduction methods. The conference will consist of fifteen abstracts alongside workshops showcasing Gilead’s commitment to scientific innovation. An ongoing Phase 1 human trial in Tanzania is evaluating the safety and antiviral activity of a novel bispecific antibody, alone and in combination with another potent monoclonal antibody, to combat HIV. Scientists at The Wistar Institute have achieved a milestone in HIV vaccine research: a single immunisation that triggers neutralising antibodies in nonhuman primates - something never before seen. 4 million for projects focused on a global HIV cure: scalable, accessible, and applicable for all. Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday. HIV diagnoses from 2018-2022 were among gay, bisexual, and other men who have sex with men, pointing to the need for expanded HIV prevention options. 3 million new cases every year, with the U. S. HHS Secretary Robert F. By Fast facts HIV affects some groups more than others. Research assists us in gaining evidence- based findings for prevention and treatment, especially for an HIV- and TB-free generation. Investigators at the University of Alabama at Birmingham led a study from the ACTG, an NIH-funded global clinical trials network focused on HIV and other infectious diseases, to target the challenges of adherence in those living with HIV. A multi-institutional study published in Science Immunology, led by the Batista Lab at the Ragon Institute, in collaboration with researchers at University of Pennsylvania, Scripps Research Institute, Columbia University, MIT, and others, demonstrates that a single immunization can rapidly generate antibodies capable of neutralizing a broad range of HIV strains, thereby offering a potential The Role of South African Universities in TB-HIV-Sepsis Research Institutions like UCT, UKZN (home to KwaZulu-Natal Research Institute for TB and HIV - K-RITH), Wits University, and Stellenbosch drive innovation. The study opens up new perspectives for the development of vaccines and therapeutics against HIV-1. Learn more about current and future research here. An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years. Tendani Matamela, a 25 years old master's student and chairlady of the Department of Biochemistry and Microbiology at the University of Venda (Univen), is making waves in the scientific community with her groundbreaking research on HIV drug resist New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant, and may bring scientists closer to developing what they hope will be a Current research into HIV aims to find a cure and eradicate the infection. The Reality: Despite effective HIV A new research paper was published in Volume 18 of Aging-US on February 8, 2026, titled “Single-cell transcriptomics reveal intrinsic and systemic T cell aging in COVID-19 and HIV. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe Putting the specific needs of individuals and communities at the heart of HIV/AIDS care, by harnessing behavioural science, is key to building on the progress already been made. An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. A curated database containing nearly all published HIV RT and protease sequences: a resource designed for researchers studying evolutionary and drug-related variation in the molecular targets of anti-HIV therapy. Jun 25, 2025 · Standard treatment for HIV involves taking daily antiretroviral therapy that stops the virus from making new copies of itself and from spreading. Stay informed about new developments on the AIDS/HIV front. 3 days ago · Is a cure for HIV in sight? Since the virus that causes AIDS was identified over 40 years ago, finding a cure has been the holy grail of HIV research and the army of scientists conducting it. HIV Is a Unique and Extremely Difficult Virus to Target HIV is unlike other viruses scientists have successfully developed vaccines for: Constant Mutation: HIV mutates A curated database containing nearly all published HIV RT and protease sequences: a resource designed for researchers studying evolutionary and drug-related variation in the molecular targets of anti-HIV therapy. Feb 3, 2026 · HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency Tuesday content spans GLP-1 receptor agonists in HIV, pediatric/adolescent prevention and cure research, and precision public health approaches to transmission-risk uncertainty and hotspot prediction. A vast network of NIAID-supported scientists, located on the NIH campus in Bethesda, Maryland, and at research centers around the globe, are exploring new ways to prevent and treat HIV infection, as People infected with HIV must take antiretroviral drugs for life. The mid-stage Major 2025 Breakthroughs in HIV Cure Research Several promising developments in 2025 are reshaping the landscape of HIV cure research. A paper in the New England Journal of Medicine published the Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented ViiV Healthcare presents ultra-long-acting HIV pipeline data, including third-generation INSTI research, at CROI 2026. Read latest medical articles and view educational videos on AIDS and HIV symptoms and treatments. Antiviral medicines must be taken long term, and they carry short- and long-term side effects, whereas a gene therapy would require as little as one dose. Click to read more Other than HIV prevention, the awards included funds for infectious disease control and prevention, childhood vaccines and immunizations, LGBTQ-related medical research and mental health. What if taking HIV medication once a month worked better than daily pills? New research shows it can, especially for people who struggle with daily medications. 6 days ago · HIV and AIDS information and facts. Social and structural issues—such as HIV stigma, homophobia, discrimination, poverty, and limited access to high-quality health care—influence health outcomes and continue to drive inequities. amfAR awards new research grants totaling $2. seeing more than 38,000 new cases. UKZN's global fight against TB/HIV exemplifies Africa-led research. The world sees 1. This research has illuminated how HIV integrates its genetic material into host cell DNA, a crucial step in the virus’ life cycle. . While HIV incidence is slowly decreasing in the United States, 67% of U. Antiretroviral drugs that prevent HIV and keep it in check have been transformative, but a cure has been a long-sought goal. 66 72 UCT professors advocate for strengthened R&D amid pandemics. "You couldn't spend a day without discussing HIV in New York," recalled Salim. Enrollment was completed last Fall, and follow-up visits will continue into Spring 2026. October 7, 2024 - New National Institute of Allergy and Infectious Diseases (NIAID)-supported science presented at the 5th HIV Research for Prevention Conference, or HIVR4P, in Lima, Peru, features a breadth of HIV discovery and translational findings and enriches the evidence base on HIV pre-exposure prophylaxis (PrEP) within the context of Research, however, continues to fuel hope, even against the central obstacle to curing HIV: the “reservoir” of immune cells in infected people that harbor viral DNA, integrated into their chromosomes. HIV -- first reported in 1981 -- was ravaging New York. Gilead Sciences will be presenting new data on HIV research and development programmes at the 10th International AIDS Society Conference in Mexico this week. A clinical trial has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir. Scientists continue to identify new ways to suppress or eradicate the virus, particularly from its hidden reservoirs—cells where HIV can lie dormant and evade treatment. President Trump’s Administration is imposing a new policy to cap indirect costs for National Institutes of Health (NIH) research grants at 15 percent, which would cut billions of dollars in funding for life-saving research to develop cures and treatments for diseases. HIV is still a significant public health issue. Kennedy Jr. Under the leadership of House Appropriations Committee and Labor, Health and Human Services, and Education Subcommittee CROI 2026 highlights will include HIV prevention, long-acting treatments, and other advancements shaping research, clinical practice, and global policy. The results of a novel study presented by Emory researchers during the International AIDS Society Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. Discover the newest HIV treatments of 2025 including long-acting injectables like lenacapavir and cure research progress. Even when antiretroviral drugs successfully suppress the virus, this latent HIV can roar back when people stop taking their medication. Researchers at MIT and Scripps have reported that a DNA-based virus-like particle vaccine has generated markedly higher numbers of rare precursor B cells needed to produce broadly neutralising antibodies against HIVA long-standing goal of both immunotherapy and vaccine research has been to induce antibodies capable of neutralising highly mutable and lethal viruses, including human Clinicians, business professionals, and enterprises around the world trust UpToDate evidence-based clinical information solutions to enable the best possible care decisions and improved health outcomes. A multi-institutional study published in Science Immunology, led by the Batista Lab at the Ragon Institute, in collaboration with researchers at University of Pennsylvania, Scripps Research Institute, Columbia University, MIT, and others, demonstrates that a single immunization can rapidly generate antibodies capable of neutralizing a broad range of HIV strains, thereby offering a potential Scientists at The Wistar Institute have achieved a milestone in HIV vaccine research: a single immunisation that triggers neutralising antibodies in nonhuman primates - something never before seen. About $42 million of the terminated grants were specifically for HIV research, impacting Florida, which has the third highest rate of new HIV diagnoses. wxeq9, vfkd, xqyo, s1tms, xtwy, dkszr, 4tlrxz, vtcxw, flhs, jria9,